Drug Markets/Zonisamide

Zonisamide

30 NDCs across 12 manufacturers|27 Generic,3 Brand

Zonisamide is used to treat partial epilepsies, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Mar 27, 2000, and the first generic was approved Dec 22, 2005. FDA's Orange Book lists 23 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $39 million on Zonisamide across 421,000 claims for 74,000 beneficiaries.

Zonisamide is available as 30 NDCs from 12 manufacturers (27 generic, 3 brand), with NADAC prices from $0.06 to $15.31 per EAthe most expensive product costs about 247× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

30

27G / 3B

Manufacturers

12

competing in market

Price Spread

$0.06 – $15.31

per EA, 29 of 30 NDCs

7d Activity

13143 flat

avg +2.6% WoW · of 30 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

30 NDCs total, 30 shown

Drug Price 7d Change
ZONEGRAN 100 MG CAPSULE
$15.3102
per EA
ZONEGRAN 25 MG CAPSULE
$12.3123
per EA
ZONISADE 100 MG/5 ML ORAL SUSP
$2.7505
per ML
-0.03%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 100 MG CAPSULE
$0.1067
per EA
-0.81%
ZONISAMIDE 50 MG CAPSULE
$0.0982
per EA
+3.61%
ZONISAMIDE 50 MG CAPSULE
$0.0982
per EA
+3.61%
ZONISAMIDE 50 MG CAPSULE
$0.0982
per EA
+3.61%
ZONISAMIDE 50 MG CAPSULE
$0.0982
per EA
+3.61%
ZONISAMIDE 50 MG CAPSULE
$0.0982
per EA
+3.61%
ZONISAMIDE 50 MG CAPSULE
$0.0982
per EA
+3.61%
ZONISAMIDE 50 MG CAPSULE
$0.0974
per EA
ZONISAMIDE 25 MG CAPSULE
$0.0620
per EA
+8.46%
ZONISAMIDE 25 MG CAPSULE
$0.0620
per EA
+8.46%
ZONISAMIDE 25 MG CAPSULE
$0.0620
per EA
+8.46%
ZONISAMIDE 25 MG CAPSULE
$0.0620
per EA
+8.46%
ZONISAMIDE 25 MG CAPSULE
$0.0620
per EA
+8.46%
ZONISAMIDE 25 MG CAPSULE
$0.0620
per EA
+8.46%
ZONISAMIDE 25 MG CAPSULE
$0.0620
per EA
+8.46%

Frequently Asked Questions

What is Zonisamide used to treat?

Zonisamide is used to treat partial epilepsies, per the National Library of Medicine's MED-RT classification.

When did Zonisamide become available as a generic?

FDA approved the first generic Zonisamide (ANDA) on Dec 22, 2005. The Orange Book currently lists 23 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Zonisamide?

In 2024, Medicare Part D spent $39 million on Zonisamide across 421,000 claims for 74,000 beneficiaries.

How many Zonisamide products are on the market?

The Zonisamide drug market contains 30 NDCs from 12 manufacturers — 27 generic and 3 brand products.

What is the price range for Zonisamide?

NADAC reference prices for Zonisamide range from $0.0620 to $15.3102 per EA — the most expensive product costs about 247× the cheapest. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.

Is generic Zonisamide cheaper than brand?

The average generic NADAC for Zonisamide is $0.0929 per EA, versus $13.8112 for brand-labeled products — brand versions average about 149× the generic price.

Which manufacturers make Zonisamide?

12 manufacturers list Zonisamide in NADAC. Ranked by number of NDCs, the largest are Viona Pharmaceuticals Inc. (4), BluePoint Laboratories (4), Glenmark Pharmaceuticals Inc., USA (4), Exelan Pharmaceuticals Inc. (3), Aurobindo Pharma Limited (3).

How has the price of Zonisamide changed recently?

Over the past 7 days, 13 Zonisamide NDCs rose and 14 fell, with a market-wide average change of +2.6%.